Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies.
Study estimates the life expectancy and years of life lost by autistic people in the UK
A new study led by UCL researchers confirms that autistic people experience a reduced life expectancy, however the number of years of life lost may
November 24, 2023